Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

about

HUS and atypical HUS.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case report.

P2860

Q33441069-31E4E5A6-0A08-4DA6-A08D-D88281381E8B Q42086661-8ADAD102-C9D2-4201-AFAD-A6D972DD9C67 Q47547095-50F4A2D3-25C6-452B-B347-879A31381642

P2860

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

Item

http://www.wikidata.org/entity/Q40593336

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

@en

type

Item

label

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

@en

prefLabel

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

@en

P1476

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

@en

P2093

Anna Jin

http://www.w3.org/2001/XMLSchema#string

Gaurang Shah

http://www.w3.org/2001/XMLSchema#string

Joline L T Chen

http://www.w3.org/2001/XMLSchema#string

Laleh Boroujerdi-Rad

http://www.w3.org/2001/XMLSchema#string

P2860

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

Atypical hemolytic uremic syndrome

Current treatment of atypical hemolytic uremic syndrome

Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

Eculizumab: a review of its use in atypical haemolytic uraemic syndrome

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura.

Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation.

Is it HIV TTP or HIV-associated thrombotic microangiopathy?

Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura.

P304

576-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CKJ/SFW035

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27478600

http://www.w3.org/2001/XMLSchema#string

P932

4957717

http://www.w3.org/2001/XMLSchema#string

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

about

P2860

P2860

Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932